NCT02468076View on ClinicalTrials.gov

Radiofrequency Ablation for Biliopancreatic Malignancy

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Pancreas CancerCholangiocarcinomaObstructive Jaundice
Interventions
DEVICE

Radiofrequency ablation (StarMed)

Radiofrequency ablation into bile duct

Trial Locations (1)

3000

University Hospitals Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT02468076 - Radiofrequency Ablation for Biliopancreatic Malignancy | Biotech Hunter | Biotech Hunter